About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

NAFLD Study: US vs Liver Biopsy

NCT04101162·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

ANNA GUIDA, medicine
CONTACT
+393288699401 anna.guida88@gmail.com

Lead

University of Roma La Sapienza

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

1. Patients who are candidates for bariatric surgery between the ages of 18 and 65,
* BMI\> 40 kg / m2, in the absence of any other comorbidity
* BMI\> 35 kg / m2, in the presence of comorbidities among those classically considered to be associated with obesity
* ICM\> 30 kg / m2, in the presence of T2DM not in glycometabolic compensation
2. Patients who are candidates for laparoscopic cholecystectomy for symptomatic calculi with BMI\> 30

You may not be if

Age ≤ 18 or ≥ 65
Any concurrent surgical procedure except cholecystectomy and hiatal hernia repair
Conversion into laparotomy surgery
Post-operative complications requiring new surgical treatment
Patient not compliant in the follow-up

The record

StatusUnknown

PhaseNot applicable

Taking part20

StartedSep 2019

UpdatedApr 1, 2020

Conditions

Non-Alcoholic Fatty Liver Disease

Where1

ICOT Latina
Latina, LT, Italy